---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-003828"
form_type: "8-K"
ticker: "HLYK"
cik: "0001680139"
company_name: "HealthLynked Corp"
filed_at: "2025-01-15T23:59:59+00:00"
generated_at: "2026-05-28T01:11:56.071060+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# HealthLynked appoints Jeremy Daniel as part-time CFO; David Rosal resigns

## Summary
- Jeremy Daniel appointed CFO effective Jan 15, 2025; replaces David Rosal who resigned without disagreement.
- Daniel works two days per week at $66K annual salary; also serves as CFO of Innoveren Scientific since 2019.
- Daniel previously CFO at Regenerative Medicine Solutions (2013-19) and controller at Omnicare (2012-14).
- Daniel holds MBA from Xavier University, BBA in Accounting from University of Cincinnati, and is a CPA.
- CEO Michael Dent cited Daniel's experience in financial operations and strategic planning as key to appointment.

## SEC filing metadata
- accession: 0001213900-25-003828
- form_type: 8-K
- ticker: HLYK
- cik: 0001680139
- company_name: HealthLynked Corp
- filed_at: 2025-01-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1680139/000121390025003828/0001213900-25-003828-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1680139/000121390025003828/ea0227787-8k_health.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-003828
- JSON: https://secwatch.observer/filing/0001213900-25-003828.json
- Plain text: https://secwatch.observer/filing/0001213900-25-003828.txt

## Key facts
- Executive change
  Jeremy Daniel was appointed as Chief Financial Officer at HealthLynked Corp.
  - Action: appointed
  - Role: Chief Financial Officer
  source text: Effective January 15, 2025, HealthLynked Corp., a Nevada corporation (the “ Company ”), appointed Jeremy Daniel, age 48, as its part-time Chief Financial Officer, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1680139/000121390025003828/0001213900-25-003828-index.htm
- Executive change
  David Rosal resigned as Chief Financial Officer at HealthLynked Corp.
  - Action: resigned
  - Role: Chief Financial Officer
  source text: Effective January 15, 2025, David Rosal tendered his resignation as Chief Financial Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1680139/000121390025003828/0001213900-25-003828-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.